Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

371
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
371
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

700
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
700
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

31
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

41
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
41

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Qualitative exploration of consultant level therapy practice in critical care.

Journal of the Intensive Care Society·2025
Same author

Beyond Borders, Beneath Words: Using Natural Language Processing to Map Student Reflections on International Service Learning to Physical Therapy Values.

Journal, physical therapy education·2025
Same author

Promoting Physical Activity in Huntington's Disease: Co-Design of a Care Partner Resource.

Journal of Huntington's disease·2024
Same author

Use of a Robotic Walking Device for Home and Community Mobility in Parkinson Disease: A Randomized Controlled Trial.

Journal of neurologic physical therapy : JNPT·2024
Same author

A cancer personalised activity and lifestyle tool (CAN-PAL): A codesign study with patients and healthcare professionals.

Journal of clinical nursing·2023
Same author

The role of community paramedicine in fall prevention: A SWOT analysis.

Journal of the American Geriatrics Society·2023

Related Experiment Video

Updated: Sep 6, 2025

Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies
05:28

Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies

Published on: October 11, 2024

683

Implementing Physiotherapy Huntington's Disease Guidelines in Clinical Practice.

Una Jones1, Deborah A Kegelmeyer2, Anne D Kloos2

  • 1School of Healthcare Sciences, Cardiff University, Cardiff, United Kingdom.

Journal of Huntington'S Disease
|June 27, 2022
PubMed
Summary

Physiotherapists find colleague support and expertise crucial for Huntington

Keywords:
Evidence-based practiceHuntington’s diseaseguidelinesphysiotherapy

More Related Videos

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

1.0K
Movement Retraining using Real-time Feedback of Performance
08:16

Movement Retraining using Real-time Feedback of Performance

Published on: January 17, 2013

13.5K

Related Experiment Videos

Last Updated: Sep 6, 2025

Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies
05:28

Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies

Published on: October 11, 2024

683
Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

1.0K
Movement Retraining using Real-time Feedback of Performance
08:16

Movement Retraining using Real-time Feedback of Performance

Published on: January 17, 2013

13.5K

Area of Science:

  • Neurology
  • Physical Therapy
  • Rehabilitation Medicine

Background:

  • Clinical practice guidelines for Huntington's disease (HD) physiotherapy are available.
  • Implementation requires understanding therapist facilitators and barriers.
  • The European Huntington's Disease Network supports evidence-based physiotherapy.

Purpose of the Study:

  • To explore facilitators and barriers to implementing recent physiotherapy clinical recommendations for Huntington's disease (HD).

Main Methods:

  • Global online survey distributed via HD networks.
  • Collected demographic data and agreement on facilitators/barriers for guideline recommendations.
  • Consensus defined as ≥70% agreement.

Main Results:

  • 32 physiotherapists responded.
  • Facilitators: colleague support (81-91%), individualized plans (72-88%), therapist expertise (81-91%).
  • Barriers: behavioral (72-81%) and cognitive impairments (75-81%), low motivation (72-78%) in HD patients.

Conclusions:

  • Physiotherapist expertise and colleague support facilitate individualized plans.
  • Further strategies needed to manage cognitive/behavioral barriers in HD for treatment implementation.